Emcure Pharmaceuticals Ltd
BSE: 544210
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 1.5K+2.3% | 1.4K+12.5% | 1.3K+15.0% | 1.1K-14.2% | 1.3K+24.2% | 1.0K-6.9% | 1.1K |
| Other Income | 25.03-81.9% | 138.30+507.8% | 22.75+5.7% | 21.52-3.9% | 22.40+15.4% | 19.41-64.7% | 54.93 |
| Total Income | 1.5K-5.2% | 1.6K+21.3% | 1.3K+14.8% | 1.1K-14.0% | 1.3K+24.1% | 1.0K-9.6% | 1.2K |
| EXPENSES | |||||||
| Expenditure | 1.2K-0.5% | 1.2K+7.8% | 1.1K+18.6% | 948.93-14.9% | 1.1K+13.6% | 980.97-5.7% | 1.0K |
| Tax | 68.56+23.5% | 55.51+37.9% | 40.27-6.1% | 42.88-7.8% | 46.49+172.7% | 17.05-47.4% | 32.44 |
| PROFIT | |||||||
| PBT | 268.67-14.5% | 314.37+99.1% | 157.89-4.7% | 165.67-11.0% | 186.05+176.6% | 67.25-43.7% | 119.36 |
| Net Profit | 200.11-22.7% | 258.85+120.1% | 117.62-4.2% | 122.79-12.0% | 139.56+178.0% | 50.20-42.2% | 86.92 |
| KEY METRICS | |||||||
| OPM % | 23.40%+4.27pp | 19.13%+1.31pp | 17.82%-2.65pp | 20.47%+1.33pp | 19.14%+21.93pp | -2.79%-0.68pp | -2.11% |
| NPM % | 13.56%-3.07pp | 16.63%+7.46pp | 9.17%-1.81pp | 10.98%+0.25pp | 10.73%+5.94pp | 4.79%-2.71pp | 7.50% |
| EPS | 10.55-22.7% | 13.65+119.8% | 6.21-4.2% | 6.48-12.1% | 7.37+178.1% | 2.65-42.6% | 4.62 |
Corporate Events
Board MeetingEMCURE
202612Oct
Board Meeting
The Board of Directors approved the draft Composite Scheme o…
BSE Filing ↗ Board MeetingEMCURE
202621Sep
Board Meeting
The 45th Annual General Meeting ("AGM") of the Members of th…
BSE Filing ↗ Board MeetingEMCURE
20266Aug
Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗ Board MeetingEMCURE
20247Nov
Board Meeting
Approval Of Unaudited Financial Results (Standalone And Cons…
BSE Filing ↗ Board MeetingEMCURE
202413Aug
Board Meeting
Approval Of Unaudited Financial Results (Standalone And Cons…
BSE Filing ↗